Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Alliance Combines the Power of Precise Single-Cell Isolation with Next Generation Sequencing
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Patient-dedicated blood gas analyzer ideal for use with ICU isolation beds
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
The SelectScience article library contains downloads on the very latest technologies being used in cancer research and diagnostics
Approval enables European HLA laboratories and those beyond Europe requiring CE mark to adopt differentiated Next Generation Sequencing (NGS) solution for HLA typing
New system delivers 5-part differential analysis from finger prick of blood
Thermo Scientific Medifuge small benchtop centrifuge provides versatility within a compact footprint
Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China
The New Shimadzu Application Hand¬book “Clinical”
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection
Fecal Immunochemical Testing (FIT) is Cost Effective Compared to Colonoscopy
An overview of new developments in the field of cancer diagnostics
Liquid biopsy test delivers high negative predictive value of 99.2% for bladder cancer
Rockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute
New clinical biomarkers have the potential to greatly improve our understanding of cancer
Domainex and Cresset Announce Drug Discovery Services Alliance